While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
A one-year, $10.3 million dollar grant from the U.S. Health Resources and Services Administration (HRSA) was awarded to increase COVID-19 vaccinations through the development and mobilization of existing community-based health and outreach workforces in the state by The University of Texas Health Science Center at Houston (UTHealth Houston).
October 4, 2022
A method that combines case investigation data from local health departments and hospitalizations records from local institutions allows for the objective detection of new waves of infection during a pandemic, according to research from UTHealth Houston.
August 8, 2022
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
May 31, 2022
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
March 18, 2022
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
January 31, 2022
A one-year, $10.3 million dollar grant from the U.S. Health Resources and Services Administration (HRSA) was awarded to increase COVID-19 vaccinations through the development and mobilization of existing community-based health and outreach workforces in the state by The University of Texas Health Science Center at Houston (UTHealth Houston).
December 9, 2021
Earlier this year, the UTHealth Center for Health Promotion and Prevention Research (CHPPR) launched Take Care, Texas, an online resource for up-to-date information on COVID-19 testing in Texas. Take Care, Texas is a part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADxUP) program, which aims to develop an adaptive intervention to increase COVID-19 testing in vulnerable communities.
August 3, 2021
The Center for Health Promotion and Prevention Research (CHPPR) recently received $500,000 from the CDC to investigate solutions that will increase confidence in COVID-19 vaccines and ultimately increase uptake.
September 18, 2020
People obtain information about important issues in different ways—it’s a fact that teams with UTHealth School of Public Health’s Department of Health Promotion and Behavioral Sciences confront constantly in their research programs and community outreach.
July 20, 2020
See how our summer semester students are learning to tackle the public health problems of today and tomorrow from their home classrooms. This the first of a two-part series. We’ll be checking in with another group of students in the next few weeks.
July 2, 2020
A working team of faculty, staff and students recently launched the TexasPandemic.org visualization dashboard, which provides real-time data analytics to monitor COVID-19 spread in the state of Texas.
